GeneOne Life Sciences

Shares of Inovio Pharmaceuticals Inc (NASDAQ: INO) were trading higher by more than 5 percent on Wednesday after the company announced that preclinical testing of SynCon, a vaccine for the Zika virus, induced "robust and durable immune responses." Inovio is developing a vaccine for...